![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](tk2753contents.gif)
Acta Cryst. (2011). E67, o1620 [ doi:10.1107/S1600536811021490 ]
Abstract: The asymmetric unit of the title compound, C6H5N5·C9H6O6, comprises a full molecule each of neutral trimesic acid (tma) and zwitterionic 5-(pyridin-1-ium-3-yl)-5H-1,2,3,4-tetrazol-5-ide (ptz). The components are linked into a two-dimensional layer by a combination of O-H
O, O-H
N, N-H
O and N-H
N hydrogen bonds parallel to the (10
) plane. Layers comprising alternating rows of tma and ptz are linked into a three-dimensional network by C-H
O and
-
interactions between tma and tetrazolate rings [centroid-centroid distance = 3.763 (2) Å], and between pyridinium and tetrazolate rings [centroid-centroid distance = 3.745 (2) Å].
Online 11 June 2011
Copyright © International Union of Crystallography
IUCr Webmaster